Navigation Links
Antipsychotic Drug Linked to Pulmonary Embolism

A case study published in the British Medical Journal suggests a common antipsychotic drug might have caused a pulmonary embolism in an otherwise healthy young man.//

A pulmonary embolism results when a blood clot that developed elsewhere in the body travels to the lung. The result can be deadly. Antipsychotic drugs have been linked to an increased risk of blood clots in the past. Specifically, studies have shown an association between blood clots and the drug clozapine.

Investigators from Norway outline the experiences of a 28-year-old man who was admitted to the hospital with a psychotic disorder. Doctors began treatment with the antipsychotic drug olanzapine at 10 milligrams per day, gradually upping the dose to 30 milligrams per day. The man also received various other medications.

After 10 weeks of treatment, the man began to complain of respiratory pain. A clinical examination showed no shortness of breath, fever, or other factors normally associated with respiratory disease. A lung scan, however, found a pulmonary embolism in the man’s left lower lobe. He was put on standard anticoagulation treatment and he recovered. Olanzapine was discontinued and the man began receiving another drug instead.

Though olanzapine is associated with weight gain, and its sedating effects might lead to inactivity -- thus predisposing someone to develop blood clots -- researchers say the man in this study did not gain additional weight after receiving olanzapine. His activity level also remained normal. Tests for blood clotting disorders also turned up negative. They say that leaves olanzapine as the primary suspect in the development of the man’s pulmonary embolism.


'"/>




Page: 1

Related medicine news :

1. New Antipsychotic Medications have Little Advantage Over Older Drugs
2. Antipsychotics – not effective in treating Alzheimer
3. No Evidence to Support Many Off-label Uses of Atypical Antipsychotics
4. Antipsychotic Drug Controls Some Symptoms in Autism Disorder
5. Scientists Uncover Cause of Antipsychotic Drug Weight Gain
6. Study Sheds Light on Value of Newer Antipsychotic Drugs for Schizophrenia
7. Low Cholesterol Linked to Severe Depression and Violent Behavior in Men
8. Cough Syrup Ingredient Linked to Stroke
9. Irregular Periods Linked to Diabetes
10. Hormones Linked To Migraines
11. Triglycerides Linked To Stroke Risk

Post Your Comments:
(Date:11/21/2009)... , Association Discusses Key Provisions of L...Care Reform ,, ST. CHARLES, Ill., Nov. 21 /PRN...presentatives passing the landmark Affordable Heal...e moving key health reform legislation forward, Co...s broken health care system. Today, AARP hosted a...
(Date:11/21/2009)... Eric J. Hall, president and ...ion of America (AFA) issued the following statemen...detection as part of the new annual wellness for M...ion and Affordable Care Act" that was introdu...k, NY (PRWEB) November 21, 2009 -- Eric J. Hall, p...
(Date:11/20/2009)... , WASHINGTON, Nov. 20 /PRNewswire-USNewswir...ing senators to modify health care reform legislat...e regarding a health insurance individual coverage... enforceable mandate will minimize adverse selecti... rules prescribed by the bill. ,, "The individu...
(Date:11/20/2009)... , CHICAGO, Nov. 20 ... the U.S. Food and Drug Administration (FDA) to es...ening chemicals. ,, Citing concern about the s...tered without the benefit of professional consulta...said that the application of chemically based toot...
(Date:11/20/2009)... , NEW YORK, Nov. 20 /PRNewswire-FirstCal...ounced that it will broadcast Doctor Radio Repo...ms , an in-depth special hosted by veteran journal....com/cgi-bin/prnh/20080819/NYTU044LOGO ) ,, Do...ow About Mammograms will air November 21 live a...
Breaking Medicine News(10 mins):Health News:AARP Hosts Rep. Bill Foster In Health Care Reform Forum 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 4Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 5
...o sell condoms in school through installation of c...hird largest political party in Australia.// ...outh Australia's state parliament, said the issue ...but they are certainly telling their friends. We c...
... marriage) is thought to bring an increased number...rriage lead to betterment in the health of both se...r gay couples also offer numerous advantages. ...y Health said that such marriages apart from healt...
... elderly who have access to help at home are hospi...// The relation and relevance of the study li...g health-care costs for older adults. The answer i... help with daily tasks, however, the need for heal...
...n that older adults with asthma are highly prone t...researchers at the University of Adelaide said adu...out asthma to suffer chronic conditions like heart...versity of Adelaide, said that, though Asthma and ...
...en should be ensured wide access to contraceptive ... not informed about latest and long-lasting contra...ns) by their physician. If only this were to be im...t study conducted by the FPA to increase contracep...
...d a meeting regarding extension of funding for the...ion of drug to women with early breast cancer. // ... with advanced breast cancer. Extension of the bud... and efficacy of the anti-cancer drug that is bein...
Other Medicine News:Health News:Help at home for the elderly would be beneficial 2Health News:Women Poorly Informed About Contraceptive Options: Doctors Blamed 2
(Date:11/20/2009)...CK, Mass. and LONDON, Nov. 20 /PRNewswire-FirstCal... today announced that it has received 510(k) clear...DA) and CE Mark approval to market its WallFlex...nt of malignant esophageal strictures (obstruction... non-resectable esophageal cancer. ,, (Photo: ...
(Date:11/20/2009)...IN LAKES, N.J., Nov. 20 ...today announced the completion of its acquisition ...mpany that develops and manufactures molecular dia...May 2009, BD and HandyLab announced an exclusive a...ular assays on the HandyLab Jaguar(TM) platform, t...
(Date:11/19/2009)...INGHAM, Ala., Nov. 19 Bi...y announced the pricing of a public offering of 5,...are, resulting in gross proceeds of $48.75 million... pursuant to an effective shelf registration state...ange Commission. BioCryst has also granted the un...
Breaking Medicine Technology:Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Experimental Urine Test Spots Appendicitis 49786 1Experimental Urine Test Spots Appendicitis 49786 2YM BIOSCIENCES REPORTS DAIICHI SANKYO ENROLLS FIRST PATIENTS IN PHASE II FIRST LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB 12750 1YM BIOSCIENCES REPORTS DAIICHI SANKYO ENROLLS FIRST PATIENTS IN PHASE II FIRST LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB 12750 2YM BIOSCIENCES REPORTS DAIICHI SANKYO ENROLLS FIRST PATIENTS IN PHASE II FIRST LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB 12750 3YM BIOSCIENCES REPORTS DAIICHI SANKYO ENROLLS FIRST PATIENTS IN PHASE II FIRST LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB 12750 4YM BIOSCIENCES REPORTS DAIICHI SANKYO ENROLLS FIRST PATIENTS IN PHASE II FIRST LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB 12750 5Capital BlueCross Products Receive Excellent National Accreditation 49781 1Capital BlueCross Products Receive Excellent National Accreditation 49781 2
...t. 28 Premier Research Group Limited,the internat...ded the Good,Clinical Practice Journal (GCPj) Awar... its Global Phase 2 Chronic Myeloid Leukemia team.... recognizes, celebrates, and rewards,corporate and... "Clinical Research Team of the Year" award honors...
... Leads Investment in Lutonix to Fund Human Clinica...ay announced the,close of a $20 million Series B f...M.D. and Lixiao Wang PhD, Lutonix is a medical dev...ialization of drug coated balloon,angioplasty tech...y and,peripheral artery stenosis caused by atheros...
Other Medicine Technology:Premier Research Honored as 'Clinical Research Team of the Year' at 2008 GCPj Awards 2Lutonix Inc. Announces $20 Million Series B Financing 2Lutonix Inc. Announces $20 Million Series B Financing 3
Snap-In Snap-Out®-II Straight Scissors Insert
Spoon/Stone Forceps, dual-incision
Optima III 45 Noninsulated Strong Forceps, without ratchet
Snap-In Snap-Out®-II Bullet Nose Dissecting Forceps Insert
Medicine Products: